Dashenlin Pharm Grp Co Ltd Total Assets
Dashenlin Pharm Grp Co Ltd total assets. Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) holds total assets worth CN¥26.83 Billion CNY (≈ $3.93 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 603233 stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Dashenlin Pharm Grp Co Ltd (2012–2025)
Total assets of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. This chart illustrates how Dashenlin Pharm Grp Co Ltd's total assets have evolved over time, based on quarterly financial data. See 603233 stock price and chart for real-time trading data and today's change.
Dashenlin Pharm Grp Co Ltd - Asset Composition Analysis
Dashenlin Pharm Grp Co Ltd Total Assets Breakdown (December 2025)
Dashenlin Pharm Grp Co Ltd total assets breakdown as of December 2025. Dashenlin Pharm Grp Co Ltd's total assets of CN¥26.83 Billion consist of 50.5% current assets and 49.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 24.6% |
| Accounts Receivable | CN¥1.26 Billion | 4.8% |
| Inventory | CN¥4.14 Billion | 15.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥1.99 Billion | 7.5% |
| Goodwill | CN¥3.47 Billion | 13.1% |
Asset Composition Trend (2012–2025)
This chart illustrates how Dashenlin Pharm Grp Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 603233 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dashenlin Pharm Grp Co Ltd's current assets represent 50.5% of total assets in 2025, a decrease from 81.1% in 2012.
- Cash Position: Cash and equivalents constituted 24.6% of total assets in 2025, up from 19.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 4.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 15.6% of total assets.
Dashenlin Pharm Grp Co Ltd Competitors by Total Assets
Key competitors of Dashenlin Pharm Grp Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SHOP APOTH. UNSP.ADR/010
F:SAE1
|
Germany | €1.21 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.13 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$347.87 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥19.91 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.31 Billion |
Dashenlin Pharm Grp Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.93 | 0.97 | 1.23 |
| Quick Ratio | 0.64 | 0.66 | 0.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.09 Billion | CN¥-459.10 Million | CN¥1.41 Billion |
Dashenlin Pharm Grp Co Ltd - Advanced Valuation Insights
This section examines the relationship between Dashenlin Pharm Grp Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.73 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 0.2% |
| Total Assets | CN¥26.49 Billion |
| Market Capitalization | $3.58 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Dashenlin Pharm Grp Co Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Dashenlin Pharm Grp Co Ltd's assets grew by 0.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Dashenlin Pharm Grp Co Ltd (2012–2025)
The table below shows the annual total assets of Dashenlin Pharm Grp Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥26.49 Billion ≈ $3.88 Billion |
+0.18% |
| 2024-12-31 | CN¥26.44 Billion ≈ $3.87 Billion |
+9.60% |
| 2023-12-31 | CN¥24.12 Billion ≈ $3.53 Billion |
+15.75% |
| 2022-12-31 | CN¥20.84 Billion ≈ $3.05 Billion |
+20.22% |
| 2021-12-31 | CN¥17.34 Billion ≈ $2.54 Billion |
+40.58% |
| 2020-12-31 | CN¥12.33 Billion ≈ $1.80 Billion |
+42.21% |
| 2019-12-31 | CN¥8.67 Billion ≈ $1.27 Billion |
+32.66% |
| 2018-12-31 | CN¥6.54 Billion ≈ $956.57 Million |
+12.27% |
| 2017-12-31 | CN¥5.82 Billion ≈ $852.05 Million |
+62.64% |
| 2016-12-31 | CN¥3.58 Billion ≈ $523.89 Million |
+34.67% |
| 2015-12-31 | CN¥2.66 Billion ≈ $389.01 Million |
+12.40% |
| 2014-12-31 | CN¥2.37 Billion ≈ $346.10 Million |
+40.71% |
| 2013-12-31 | CN¥1.68 Billion ≈ $245.96 Million |
+68.67% |
| 2012-12-31 | CN¥996.51 Million ≈ $145.82 Million |
-- |
About Dashenlin Pharm Grp Co Ltd
DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.